blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3784346

EP3784346 - A COMPOSITION FOR TREATING ONE OR MORE ESTROGEN RELATED DISEASES [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  22.02.2024
Database last updated on 25.09.2024
FormerRequest for examination was made
Status updated on  29.01.2021
FormerThe international publication has been made
Status updated on  01.11.2019
Formerunknown
Status updated on  08.06.2019
Most recent event   Tooltip13.07.2024New entry: Application deemed to be withdrawn: despatch of communication + time limit 
Applicant(s)For all designated states
LifeArc
7th Floor Lynton House
7-12 Tavistock Square
London, Greater London WC1H 9LT / GB
[2021/09]
Inventor(s)01 / LARSEN, Finn
18 Forest Road Bronchester Bridge
Hawick TD9 8JS / GB
02 / MACLEAN, Carol Marion
25 Balmuir Avenue West Lothian
Bathgate EH48 4BW / GB
 [2021/09]
Representative(s)Holme Patent A/S
Valbygårdsvej 33
2500 Valby / DK
[2021/09]
Application number, filing date19727289.125.04.2019
[2021/09]
WO2019EP60570
Priority number, dateEP2018016941926.04.2018         Original published format: EP 18169419
[2021/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019207026
Date:31.10.2019
Language:EN
[2019/44]
Type: A1 Application with search report 
No.:EP3784346
Date:03.03.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 31.10.2019 takes the place of the publication of the European patent application.
[2021/09]
Search report(s)International search report - published on:EP31.10.2019
ClassificationIPC:A61P5/30, A61K38/09
[2021/09]
CPC:
A61P5/30 (EP,IL,KR); A61K38/09 (EP,IL,KR,US); A61P5/32 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/09]
Extension statesBA26.11.2020
ME26.11.2020
Validation statesKH26.11.2020
MA26.11.2020
MD26.11.2020
TN26.11.2020
TitleGerman:ZUSAMMENSETZUNG ZUR BEHANDLUNG EINER ODER MEHRERER ÖSTROGENVERMITTELTER KRANKHEITEN[2021/09]
English:A COMPOSITION FOR TREATING ONE OR MORE ESTROGEN RELATED DISEASES[2021/09]
French:COMPOSITION POUR TRAITER UNE OU PLUSIEURS MALADIES LI& XC9;ES AUX & X152;STROG& XC8;NES[2021/09]
Entry into regional phase26.11.2020National basic fee paid 
26.11.2020Designation fee(s) paid 
26.11.2020Examination fee paid 
Examination procedure12.02.2020Request for preliminary examination filed
International Preliminary Examining Authority: EP
26.11.2020Examination requested  [2021/09]
26.11.2020Date on which the examining division has become responsible
24.06.2021Amendment by applicant (claims and/or description)
21.02.2024Despatch of a communication from the examining division (Time limit: M04)
12.07.2024Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
Fees paidRenewal fee
30.04.2021Renewal fee patent year 03
02.05.2022Renewal fee patent year 04
02.05.2023Renewal fee patent year 05
30.04.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO9520972  (HAMPTON ROADS MEDICAL COLLEGE [US]) [A] 1-12* claims 1,8,13-14 *;
 [Y]WO9603138  (HAMPTON ROADS MEDICAL COLLEGE [US], et al) [Y] 1-11 * page 24, lines 2-10,12-13; claims 8,9 * * page 7, line 7 - page 8, line 4 * * page 13, lines 11-14,20-21 *;
 [XY]WO0121194  (ASTA MEDICA AG [DE], et al) [X] 12 * page 5, lines 5-9; figures 1,2; claims 1,2,9-13 * * page 6, lines 6-24 * * page 8, lines 27-30 * [Y] 1-11;
 [XA]US2002177556  (ENGEL JURGEN [DE], et al) [X] 12 * paragraphs [0005] , [0006]; claims 1,3-10 * [A] 1-11;
 [XY]WO03006049  (FERRING BV [NL], et al) [X] 12 * page 6, paragraph 2; claims 27-31 * [Y] 1-11;
 [Y]  - Jacques Donnez, "Partial suppression of estradiol: a new strategy in endometriosis management?", Fertility and Sterility, (20170301), pages 568 - 570, URL: https://www.fertstert.org/article/S0015-0282(17)30056-0/pdf, (20180802), XP055497090 [Y] 1-11 * page 568, column 2, paragraphs 18-24 * * last paragraph; page 568 - page 569 * * page 569, column 2, paragraph 2 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.